“UK-China collaboration to tackle antimicrobial resistance”

“The Department of Health and Social Care (DHSC) is working with Innovate UK to invest up to £10 million of Official Development Assistance (ODA) funding. This will be in bilateral research and development (R&D) projects between the UK and China. The funding will address the growing threat of antimicrobial resistance (AMR).

This competition is for innovative projects that support the development and, where appropriate, clinical evaluation of new products or services. These products or services must be of value in addressing the threat from AMR. The Chinese Ministry of Science and Technology (MoST) will invest up to 60 million RMB to fund the Chinese partners.

UK applicants must demonstrate that projects are primarily and directly relevant to the needs of people in low and middle income countries (LMICs), including China, as defined by the Organisation for Economic Co-operation and Development (OECD). There must be a clear economic and societal benefit to LMICs from their proposed project.”

Suorce: Innovate UK